2030 Targeted Protein Degradation Therapies 
Drug Discovery World
OCTOBER 6, 2022
until 2030. Scientific and technological breakthroughs are on the horizon in areas such as targeted protein degradation, cell antigene therapies to customise drugs and monoclonal antibodies being modified in new ways.” . Lu Rahman highlights some of the key players. . Valued at $14.8 References: .
Drug Discovery World
MAY 30, 2023
From antibody-drug conjugates and RNA, to CRISPR and CAR-T therapy, DDW asked the drug discovery industry what the most important development in oncology over the last five years has been. Immunopheresis is a ‘subtractive therapy,’ in contrast to alternative drugs that constitute ‘additive’ therapies.
Expert insights. Personalized for you.
130 
Let's personalize your content